Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study

NCT06411028 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06411028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 1, 2025
Completion date
January 30, 2027
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dystonic tremor syndrome